Highlights
Profile claimed by owner
About
Recombinant Therapeutic Proteins for Rare Autoimmune Diseases
Taxon Therapeutics is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins for rare autoimmune diseases with unmet need. The company's product, TAX-01, is designed for the treatment of adults with autoimmune hemolytic anemia, a severe and rare blood disorder that occurs when antibodies directed against the person's own red blood cells cause them to burst, leading to an insufficient number of oxygen-carrying red blood cells in circulation.
Identity
| Name | Taxon Therapeutics |
|---|---|
| Slug | taxon-therapeutics |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4NPO4IwLDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Apr 2024 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Herzliya |
| HQ address | Bar Kokhva Street 122, Herzliya, Israel |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2B
Tags
therapeuticsrare-diseasesbiotechnologyautoimmune-diseasespharmaceuticalsdrug-developmenthematologyorphan-drug
Funding
| Total raised | — |
|---|---|
| Current stage | Pre-Funding |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}